# gemcitabine

NDC: 25021-235
Generic name: gemcitabine hydrochloride
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20141229

FDA application: ANDA202485

## Active ingredients

- GEMCITABINE HYDROCHLORIDE: 1 g/25mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-235"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-235
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44bcc16c-341d-49e8-a1c6-95d084667aca
